Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Responsible Signaling Pathway for Adrenergic Beta-3 Receptor Regulation in Human Subcutaneous White Adipose Tissue

NCT05634174 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05634174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05634174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Responsible Signaling Pathway for Adrenergic Beta-3 Receptor Regulation in Human Subcutaneous White Adipose Tissue
Lead sponsor
University of California, San Diego
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 1, 2023
Completion date
December 31, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, prediabetes